Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Colorectal Carcinoma (CRC) Patients”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT01490996
What this trial is testing

Combining Curcumin With FOLFOX Chemotherapy in Patients With Inoperable Colorectal Cancer

Who this might be right for
Colonic CancerMetastasis
University of Leicester 41
Testing effectiveness (Phase 2)Study completedNCT03485027
What this trial is testing

Rechallenge of Prior Regimen in Third or Later-line Chemotherapy in Metastatic Colorectal Cancer

Who this might be right for
Metastatic Colorectal CancerChemotherapy Effect
Fudan University 43
Testing effectiveness (Phase 2)Study completedNCT02699073
What this trial is testing

Evaluation of Treatment Response With CHOI and RECIST Criteria and CT Texture Analysis in Patients With Metastatic Colorectal Cancer Treated With Regorafenib

Who this might be right for
Metastatic Colorectal Cancer
GERCOR - Multidisciplinary Oncology Cooperative Group 55
Early research (Phase 1)Not Yet RecruitingNCT07587827
What this trial is testing

Study Evaluating the Safety Feasibility and Efficacy of ODI-2001 Vaccine, a Personnalized Immunotherapy in Patients With Metastatic or Locally Advanced Colon Cancer or Pancreatic Cancer

Who this might be right for
Metastatic Colorectal Cancer (CRC)Locally Advanced Colorectal CancerMetastatic Pancreatic Cancer+1 more
Centre Georges Francois Leclerc 77
Not applicableWithdrawnNCT01031056
What this trial is testing

Collection of Biospecimen & Clinical Information in Patients w/ Gastrointestinal Cancers

Who this might be right for
Gastrointestinal NeoplasmsGynecologic CancersGynecologic Cancers Cervical Cancer+11 more
Stanford University
Large-scale testing (Phase 3)Study completedNCT03281096
What this trial is testing

A Research of Berberine Hydrochloride to Prevent Colorectal Adenomas in Patients With Previous Colorectal Cancer

Who this might be right for
Colorectal Adenomas
Xijing Hospital of Digestive Diseases 1,000
Not applicableStudy completedNCT04716062
What this trial is testing

Short-term and Oncological Outcomes of Laparoscopic Colorectal Cancer Surgery in Obese Patients

Who this might be right for
ObesityColorectal Cancer
Azienda Ospedaliera Specializzata in Gastroenterologia Saverio de Bellis 138
Not applicableStudy completedNCT00199862
What this trial is testing

Safety Study of Radio-labeled huA33 Antibody in Colorectal Cancer

Who this might be right for
Colorectal NeoplasmsColorectal CancerColorectal Tumor+1 more
Memorial Sloan Kettering Cancer Center 30
Testing effectiveness (Phase 2)Study completedNCT01722162
What this trial is testing

Levocetirizine + Capecitabine + Bevacizumab for Patients With Refractory Colorectal Cancer

Who this might be right for
Colorectal Neoplasms
Washington University School of Medicine 47
Testing effectiveness (Phase 2)Active Not RecruitingNCT05700656
What this trial is testing

Galunisertib Combined With Capecitabine in Advanced CRC With PM

Who this might be right for
Colorectal Cancer MetastaticPeritoneal Carcinomatosis
The Netherlands Cancer Institute 31
Large-scale testing (Phase 3)Study completedNCT00005979
What this trial is testing

Combination Chemotherapy With or Without Irinotecan in Treating Patients With Stage III Colon Cancer

Who this might be right for
Colorectal Cancer
UNICANCER
Testing effectiveness (Phase 2)Ended earlyNCT00819754
What this trial is testing

A Phase I/II Study of IXO With Bevacizumab in Patients With Metastatic Colorectal Cancer

Who this might be right for
Metastatic Colorectal Cancer
Ottawa Hospital Research Institute 23
Testing effectiveness (Phase 2)Study completedNCT00019331
What this trial is testing

Vaccine Therapy Plus Biological Therapy in Treating Adults With Metastatic Solid Tumors

Who this might be right for
Colorectal CancerEndometrial CancerHead and Neck Cancer+6 more
National Cancer Institute (NCI)
Testing effectiveness (Phase 2)Study completedNCT00077259
What this trial is testing

Epothilone D as Second-Line Treatment for Patients With Advanced or Metastatic Refractory Colorectal Cancer

Who this might be right for
Colorectal Cancer
Memorial Sloan Kettering Cancer Center
Not applicableStudy completedNCT03140917
What this trial is testing

Multimodal Assessment of Liver Volume and Function

Who this might be right for
Colorectal CancerLiver Metastases
Karolinska University Hospital 10
Not applicableStudy completedNCT03888313
What this trial is testing

Pretreatment Group Consultation for Patients With Colorectal Cancer

Who this might be right for
Colorectal Neoplasm
Sahlgrenska University Hospital 161
Early research (Phase 1)Looking for participantsNCT06825624
What this trial is testing

ARTEMIS-102: HS-20093 Combinations in Patients with Advanced Metastatic Colorectal Cancer

Who this might be right for
Metastatic Colorectal Cancer (CRC)
Hansoh BioMedical R&D Company 560
Not applicableUnknownNCT02045680
What this trial is testing

RADOX' Reduced Abdominal Distension and Oxygen Delivery

Who this might be right for
Colorectal Cancer
Dr Michael Scott 30
Early research (Phase 1)Ended earlyNCT03203525
What this trial is testing

Combination Chemotherapy and Bevacizumab With the NovoTTF-100L(P) System in Treating Participants With Advanced, Recurrent, or Refractory Hepatic Metastatic Cancer

Who this might be right for
Advanced Malignant NeoplasmColorectal Carcinoma Metastatic in the LiverMetastatic Malignant Neoplasm in the Liver+1 more
M.D. Anderson Cancer Center 38
Testing effectiveness (Phase 2)Study completedNCT00284817
What this trial is testing

Phase I Study of MEDI522 in Patients With Irinotecan-Refractory Advanced Colorectal Cancer

Who this might be right for
Cancer
MedImmune LLC 17
Next Page